Heat Waves and the Elderly - Cooling Modalities

April 17, 2024 updated by: Craig Crandall, University of Texas Southwestern Medical Center

Heat Waves in the Elderly: Reducing Thermal and Cardiovascular Consequences

The purpose of this study is to assess how well cooling modalities work in reducing cardiovascular stress of the elderly to heat wave conditions

Study Overview

Detailed Description

Heat waves are lethal and cause a disproportionate number of deaths in the elderly relative to any other age group. Such deaths are primarily cardiovascular, not hyperthermia itself, in origin. The central hypothesis of this work is that cardiovascular stress during heat wave conditions in the elderly can be reduced by applying low-energy cooling modalities. Comprehensive cardiovascular and thermal responses in the elderly will be evaluated during exposure to two prolonged heat wave conditions: hot and humid (replicating the 1995 Chicago heat wave), very hot and dry (replicating the 2018 Los Angeles heat wave). With each of these heat wave conditions individuals will be exposed to the following cooling modalities: no cooling (control), water spray, fan use, and fan use plus water spray.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 65 years of age or older
  • Free of any significant underlying medical problems based upon a detailed medical history and physical exam

Exclusion Criteria:

  • Known heart disease
  • Other chronic medical conditions requiring regular medical therapy including cancer, diabetes, uncontrolled hypertension, and uncontrolled hypercholesterolemia etc;
  • Abnormality detected on routine screening suggestive of provokable ischemia or previously undetected cardiac disease or resting left bundle branch block on screening electrocardiogram.
  • Current smokers, as well as individuals who regularly smoked within the past 3 years
  • Subject with a body mass index ≥31 kg/m2
  • Pregnant individuals

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Very hot and dry
Subjects will be exposed to 3 hours in a climate chamber set to approximately 47 deg C and 15% relative humidity, which reflects a very hot and dry heat wave condition similar to the 2018 Los Angeles heat wave. Four visits will be required to complete this arm, with each visit a different cooling modality applied.
Participants will receive water spraying on their body throughout the climate chamber exposure.
Participants will be exposed to a fan throughout the climate chamber exposure.
Participants will receive both water spraying and a fan throughout the climate chamber exposure.
Participants will NOT receive either water spray or a fan exposure.
Experimental: Hot and humid
Subjects will be exposed to 3 hours in a climate chamber set to approximately 41 deg C and 40% relative humidity, which reflects hot and humid heat wave similar to the 1995 Chicago heat wave. Four visits will be required to complete this arm, with each visit a different cooling modality applied.
Participants will receive water spraying on their body throughout the climate chamber exposure.
Participants will be exposed to a fan throughout the climate chamber exposure.
Participants will receive both water spraying and a fan throughout the climate chamber exposure.
Participants will NOT receive either water spray or a fan exposure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in core body temperature
Time Frame: Body core temperature will be obtained within 60 min before the heat wave exposure after the 3 hour heat wave exposure.
Change in core body temperature will be measured either from a temperature sensor pill or from a rectal thermometer
Body core temperature will be obtained within 60 min before the heat wave exposure after the 3 hour heat wave exposure.
Change in left ventricular function
Time Frame: Within 60 minutes before each simulated heat wave exposure, around minute 90 of the heat wave exposure, and at the end of the 3 hour heat wave exposure
Measures of left ventricular function, such as ventricular wall motion and ventricular filling, will be obtained from echocardiography images.
Within 60 minutes before each simulated heat wave exposure, around minute 90 of the heat wave exposure, and at the end of the 3 hour heat wave exposure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: Prior to and throughout each simulated heat wave exposure; approximately 420 minutes
Heart rate will be measured from ECG electrodes attached to the participant
Prior to and throughout each simulated heat wave exposure; approximately 420 minutes
Cardiac output
Time Frame: Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)
Cardiac output (how much blood is ejected from the heart) will be measured using 3D echocardiography.
Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)
Arterial blood pressure
Time Frame: Prior to and throughout each simulated heat wave exposure; an average of 480 minutes
Arterial blood pressure will be measured using a standard arm blood pressure cuff.
Prior to and throughout each simulated heat wave exposure; an average of 480 minutes
Whole body sweat rate
Time Frame: Within 60 minutes before each simulated heat wave exposure and within 30 minutes after each heat wave exposure.
Whole body sweat rate will be measured by through nude weight of the participant.
Within 60 minutes before each simulated heat wave exposure and within 30 minutes after each heat wave exposure.
Markers of renal function and injury - Cystatin C
Time Frame: Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Markers of renal function and injury (e.g., cystatin C) will be evaluated from blood sampling collection.
Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Markers of renal function and injury - Creatinine Clearance
Time Frame: Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Markers of renal function and injury (e.g., creatinine clearance) will be evaluated from blood sampling and urine collection.
Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Markers of renal function and injury - Insulin-like growth factor-binding protein 7
Time Frame: Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Markers of renal function and injury (e.g., Insulin-like growth factor-binding protein 7) will be evaluated from urine sampling.
Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Markers of renal function and injury - Tissue inhibitor of metalloproteinases 2
Time Frame: Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Markers of renal function and injury (e.g., Tissue inhibitor of metalloproteinases 2) will be evaluated from urine sampling.
Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Cerebral perfusion
Time Frame: Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)
Cerebral perfusion will be measured by Doppler ultrasound of the internal carotid and vertebral arteries.
Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)
High sensitive cardiac troponin
Time Frame: Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
A plasma-based marker of cardiac stress (high sensitive cardiac troponin) be evaluated from blood sampling.
Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
Skin temperature
Time Frame: Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)
Skin temperature will be measured from small temperature sensitive electrodes attached to the participant's skin
Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)
Forced vital capacity (FVC)
Time Frame: Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)
Forced vital capacity will be obtained from spirometry
Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 21, 2023

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

July 27, 2022

First Submitted That Met QC Criteria

July 29, 2022

First Posted (Actual)

August 2, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2024

Last Update Submitted That Met QC Criteria

April 17, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STU-2022-0625

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperthermia

Clinical Trials on Water Spray

3
Subscribe